Corpus Intelligence IC Memo — INTEGRIS HEALTH EDMOND 2026-04-26 08:02 UTC
IC Memo — INTEGRIS HEALTH EDMOND
Investment Committee Memorandum | OK | 77 beds | Grade D | EBITDA uplift $8.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

INTEGRIS HEALTH EDMOND

CCN 370236 | OKLAHOMA, OK | 77 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

INTEGRIS HEALTH EDMOND is a 77-bed suburban community hospital in OKLAHOMA, OK with $119.4M in net patient revenue and a -3.8% operating margin. The hospital serves a payer mix of 29.5% Medicare, 23.3% Medicaid, and 47.2% commercial.

Thesis: Turnaround. Our ML models identify $8.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.8% to 3.5% (+736bps).

Net Revenue HCRIS$119.4M
Current EBITDA COMPUTED$-4.6M
Operating Margin COMPUTED-3.8%
Occupancy HCRIS51.9%
Revenue / Bed COMPUTED$1.6M
Net-to-Gross HCRIS17.6%
Distress Probability ML50.6%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
57
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of -3.8% places it above the state median. Among 57 size-comparable peers (38-154 beds), the median margin is -3.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (38-154), prioritizing same-state peers. 57 hospitals in the comp set.

HospitalStateBedsRevenueMargin
INTEGRIS HEALTH EDMOND (Target)OK77$119.4M-3.8%
OKLAHOMA HEART HOSPITALOK97$342.0M-2.8%
STILLWATER MEDICAL CENTEROK52$270.2M-9.9%
HILLCREST HOSPITAL SOUTHOK152$218.9M4.9%
SAINT FRANCIS HOSPITAL SOUTHOK104$198.3M34.4%
ST ANTHONY SHAWNEE HOSPITALOK57$169.2M-6.1%
MCBRIDE CLINIC ORTHOPEDIC HOSPOK68$166.9M-5.0%
MERCY HOSPITAL ARDMOREOK140$158.8M-1.1%
OKLAHOMA HEART HOSPITAL SOUTHOK43$148.5M-0.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.5M+210bp18mo
Cost to Collect4.5%2.5%$2.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.5M+122bp9mo
Clean Claim Rate88.0%96.0%$76K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.5M
Cost to Collect
$2.4M
Denial Rate Reduction
$2.4M
A/R Days Reduction
$1.5M
Clean Claim Rate
$76K
Total EBITDA Uplift$8.8M
Current EBITDA$-4.6M
+ RCM Uplift+$8.8M
Pro Forma EBITDA$4.2M
Current Margin-3.8%
Pro Forma Margin3.5%
WC Released (1x)$4.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-7.1M$57.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-7.1M$61.0M0.00x-100.0%
Bull Case9.0x11.0x$-6.4M$87.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-6.4M$93.8M0.00x-100.0%
Bear Case11.0x10.0x$-7.8M$15.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-7.8M$15.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumElevated Medicaid exposure (23.3%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 50.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 57 hospitals with 38-154 beds
  • Same-state prioritization (n=58)
  • Comp margins: P25=-17.3% / P50=-3.8% / P75=5.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.